Literature DB >> 2357036

The Angelchik antireflux device: a 5-year experience.

A G Timoney1, J M Kelly, M R Welfare.   

Abstract

A total of 44 patients had an Angelchik antireflux prosthesis inserted over a 5-year period. Of these, 41 were available for review and were assessed by interview using a modified Visick grading. Of the 23 patients followed up for a minimum of 3 years 74% had an excellent or satisfactory outcome; 92% of patients with symptoms of reflux obtained relief, but less than 50% of those patients presenting with dysphagia had a satisfactory outcome. The incidence of mild postoperative dysphagia increased the longer the period of follow-up. The main cause of a Visick 3 or 4 result was prosthesis migration. We have modified our technique of insertion to reduce these complications, and in a more recent series have achieved a Visick Grade 1 or 2 in up to 92% of patients. We conclude that dysphagia is a relative contraindication to the insertion of the Angelchik prosthesis. Our recent results encourage the use of the prosthesis provided steps are taken to reduce the incidence of migration and pericapsular fibrous tissue formation.

Entities:  

Mesh:

Year:  1990        PMID: 2357036      PMCID: PMC2499170     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  16 in total

1.  Gastropexy and "fundoplication" in surgical treatment of hiatal hernia.

Authors:  R NISSEN
Journal:  Am J Dig Dis       Date:  1961-10

2.  A quantitative assessment of results with the Angelchik prosthesis.

Authors:  J A Sapala; M A Sapala
Journal:  Ann R Coll Surg Engl       Date:  1986-05       Impact factor: 1.891

3.  Effective surgical therapy of esophagitis. Experience with Belsey, Hill, and Nissen operations.

Authors:  L F Sillin; R E Condon; S D Wilson; L W Worman
Journal:  Arch Surg       Date:  1979-04

4.  Surgical management of esophageal reflux and hiatus hernia. Long-term results with 1,030 patients.

Authors:  D B Skinner; R H Belsey
Journal:  J Thorac Cardiovasc Surg       Date:  1967-01       Impact factor: 5.209

5.  Post-fundoplication symptoms. Do they restrict the success of Nissen fundoplication?

Authors:  J B Negre
Journal:  Ann Surg       Date:  1983-12       Impact factor: 12.969

6.  A quantitative assessment of results with the Angelchik prosthesis.

Authors:  J H Wyllie; D A Edwards
Journal:  Ann R Coll Surg Engl       Date:  1985-07       Impact factor: 1.891

7.  Randomized prospective trial of the Angelchik anti-reflux prosthesis.

Authors:  M W Gear; E W Gillison; B L Dowling
Journal:  Br J Surg       Date:  1984-09       Impact factor: 6.939

8.  The Angelchik anti-reflux prosthesis--some reservations.

Authors:  D Durrans; C P Armstrong; T V Taylor
Journal:  Br J Surg       Date:  1985-07       Impact factor: 6.939

9.  Prospective study of the Angelchik anti-reflux prosthesis.

Authors:  R J Wale; C M Royston; J R Bennett; G K Buckton
Journal:  Br J Surg       Date:  1985-07       Impact factor: 6.939

10.  Reflux versus dysphagia: an objective evaluation of the Angelchik prosthesis.

Authors:  D L Morris; J Jones; D F Evans; G Foster; H Smart; R Gregson; S Amar; J Doran; J D Hardcastle
Journal:  Br J Surg       Date:  1985-12       Impact factor: 6.939

View more
  4 in total

Review 1.  Surgery for uncomplicated gastrooesophageal reflux.

Authors:  T C Dehn
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

Review 2.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

3.  An objective long-term evaluation of the Angelchik antireflux prosthesis.

Authors:  D F Evans; C S Robertson; D L Morris; S J Ledingham; J Doran; J D Hardcastle
Journal:  Ann R Coll Surg Engl       Date:  1991-11       Impact factor: 1.891

4.  Laparoscopic Removal of Angelchik Prosthesis Followed by Interval Sleeve Gastrectomy.

Authors:  Faryal G Afridi; Morgan Johnson; Kelsey A Musgrove; Salim Abunnaja; Lawrence E Tabone; David C Borgstrom; Nova Szoka
Journal:  Case Rep Surg       Date:  2019-05-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.